Management of Constipation
Polyethylene glycol (PEG) is recommended as first-line pharmacological treatment for constipation, with a standard dose of 17g dissolved in 4-8 ounces of beverage once daily. 1
Initial Assessment and Classification
Constipation is defined by symptoms including:
- Infrequent bowel movements (less than 3 per week)
- Hard stools
- Straining during defecation
- Sensation of incomplete evacuation
- Need for manual maneuvers during defecation
Digital rectal examination should be performed to assess for fecal impaction, which would require disimpaction before maintenance therapy 2
Step-by-Step Management Algorithm
Step 1: Lifestyle Modifications (as adjuncts to pharmacological treatment)
- Increase fluid intake and physical activity 1
- Gradually increase dietary fiber to 20-25g per day, focusing on soluble fiber 1
- Optimize toileting habits:
Step 2: First-line Pharmacological Treatment
- Osmotic Laxatives (preferred first-line option):
Step 3: If Inadequate Response to Osmotic Laxatives
- Add Stimulant Laxatives:
Step 4: For Opioid-Induced Constipation
- Prophylactically prescribe laxatives when initiating opioid therapy 1
- Increase laxative dose when increasing opioid dose 1
- Consider peripherally acting mu-opioid receptor antagonists (PAMORAs) for unresolved OIC, but not as first-line treatment 2, 1
Step 5: For Rectal Loading or Fecal Impaction
- Use suppositories and enemas as first-line therapy when digital rectal examination identifies a full rectum or fecal impaction 2
- Isotonic saline enemas are preferable in older adults 2
- Contraindications for enemas: neutropenia, thrombocytopenia, paralytic ileus, intestinal obstruction, recent colorectal surgery, severe colitis, undiagnosed abdominal pain 2
Special Considerations
Elderly Patients
- Ensure access to toilets, especially with decreased mobility 2
- Provide dietetic support 2
- PEG (17 g/day) offers an efficacious and tolerable solution 2
- Avoid liquid paraffin for bed-bound patients and those with swallowing disorders 2
- Use saline laxatives cautiously due to risk of hypermagnesemia 2
Specific Agents to Avoid or Use Cautiously
Bulk-forming laxatives (psyllium, methylcellulose):
Stool softeners (docusate sodium):
Monitoring and Follow-up
- Reassess treatment efficacy within 2-4 weeks of initiating treatment 1
- Adjust the plan as needed based on response 1
- Evaluate for fecal impaction if symptoms persist despite treatment 1
Common Pitfalls to Avoid
- Relying solely on lifestyle modifications without appropriate pharmacological intervention 1
- Using fiber supplements in patients with suspected obstruction 1
- Continuing ineffective treatments without reassessment 1
- Failing to prophylactically treat constipation when prescribing opioids 1
- Using oral laxatives containing sodium phosphate in patients at risk for renal dysfunction 1